SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
GeoVax
An SI Board Since October 2008
Posts SubjectMarks Bans Symbol
4 2 0 GOVX
Emcee:  Don Hand Type:  Moderated
GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus). Studies evaluating these vaccines in HIV/AIDS infected individuals are in the planning stage.

Company web site
geovax.com

Other forums

ragingbull.quote.com

siliconinvestor.com

HIV Vaccine Trials Network
hvtn.org

Magazine
genengnews.com

Google news search GeoVax
news.google.com

Google news search Emory and HIV
news.google.com

Partners:
VIVALIS for Use of its Revolutionary EBx® Technology to Manufacture
its MVA HIV/AIDS Vaccine
finance.yahoo.com

Emory University in Atlanta, Georgia (4/28/08) held 233,905,253 shares 32.0%
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):